1 Min Read
Feb 9 (Reuters) - Solasia Pharma KK
* Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability
Source text in Japanese:goo.gl/inouVL
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.